Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study

臺大醫院;臺大醫院-泌尿部;Ye, D.D.YeAhn, H.H.AhnPu, Y-S.Y-S.PuWeiqing, H.H.WeiqingXie, L-P.L-P.XieHuang, S-P.S-P.HuangWu, H-C.H-C.WuMa, L.L.MaYamada, S.S.YamadaNoda, S.S.NodaSun, Y.Y.Sun蒲永孝2017-09-272018-07-112017-09-272018-07-112016http://ntur.lib.ntu.edu.tw//handle/246246/283643[SDGs]SDG3Efficacy and safety of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC) following androgen deprivation therapy (ADT): An Asian multinational study10.1093/annonc/mdw372.33